Why are statin prescribing guidelines for primary prevention not always followed in primary care?

about

Why are statin prescribing guidelines for primary prevention not always followed in primary care?

Item

http://www.wikidata.org/entity/Q39335837

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Why are statin prescribing gui ...... ways followed in primary care?

@en

Why are statin prescribing gui ...... ways followed in primary care?

@nl

type

Item

label

Why are statin prescribing gui ...... ways followed in primary care?

@en

Why are statin prescribing gui ...... ways followed in primary care?

@nl

prefLabel

Why are statin prescribing gui ...... ways followed in primary care?

@en

Why are statin prescribing gui ...... ways followed in primary care?

@nl

P1476

Why are statin prescribing gui ...... ways followed in primary care?

@en

P2093

Joanna Sheldon

http://www.w3.org/2001/XMLSchema#string

Nicholas Steel

http://www.w3.org/2001/XMLSchema#string

Robert Fleetcroft

http://www.w3.org/2001/XMLSchema#string

Yasmeen Hassan

http://www.w3.org/2001/XMLSchema#string

P2860

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia.

Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study.

Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalink

Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.

A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.

Implications of lower risk thresholds for statin treatment in primary prevention: analysis of CPRD and simulation modelling of annual cholesterol monitoring

Using quantitative risk information in decisions about statins: a qualitative study in a community setting.

P304

536-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3399/BJGP16X687481

http://www.w3.org/2001/XMLSchema#string

P433

651

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John Ford

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27688515

http://www.w3.org/2001/XMLSchema#string

P932

5033302

http://www.w3.org/2001/XMLSchema#string